Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Gynecologic Tumors”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Testing effectiveness (Phase 2)Ended earlyNCT04527900
What this trial is testing

The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach

Who this might be right for
Endometrial Cancer
University of Maryland, Baltimore 2
Early research (Phase 1)Ended earlyNCT04691375
What this trial is testing

PY314 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorGynecologic CancerBreast Cancer+6 more
Ikena Oncology 86
Very early researchLooking for participantsNCT05098171
What this trial is testing

GC201 TIL in Advanced Gynecologic Tumors (10hospital)

Who this might be right for
Advanced Gynecologic TumorsSignal Switch Receptor Modified TILTreatment Side Effects+1 more
Shanghai Juncell Therapeutics 50
Testing effectiveness (Phase 2)Study completedNCT00390234
What this trial is testing

Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma

Who this might be right for
Fallopian Tube CancerFemale Reproductive CancerOvarian Carcinosarcoma+9 more
National Cancer Institute (NCI) 63
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07311538
What this trial is testing

Phase IIa Study of BRY812 Monotherapy in Advanced Gynecological Malignancies

Who this might be right for
Advanced Gynecological Malignancies
BioRay Pharmaceutical Co., Ltd. 56
Early research (Phase 1)Active Not RecruitingNCT05704985
What this trial is testing

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

Who this might be right for
CancerSolid TumorColorectal Cancer+6 more
DEKA Biosciences 39
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07406789
What this trial is testing

Phase II, Prospective, Randomized, Proof-of-concept Study to Evaluate the Effects of a Personalized Dietary Intervention in Women With Advanced Gynecologic or Breast Tumors Treated With Antibody-Drug Conjugates (ADCs).

Who this might be right for
Gynecologic CancersAdvanced Breast Cancer
TNC Nutrición Terapéutica S.L. 100
Not applicableLooking for participantsNCT06626269
What this trial is testing

Identification of Innovative Biomarkers Related to the Immune System or Tumor Microenvironment to Promote the Efficacy of Immunotherapies

Who this might be right for
Advanced Digestive CancerAdvanced Gynecologic Cancer
Centre Hospitalier Universitaire de Besancon 700
Testing effectiveness (Phase 2)Study completedNCT00511992
What this trial is testing

Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer

Who this might be right for
Advanced Ovarian CarcinomaPrimary Peritoneal CarcinomaOvarian Carcinosarcoma
University of Oklahoma 20
Early research (Phase 1)Study completedNCT03101280
What this trial is testing

A Combination Study of Rucaparib and Atezolizumab in Participants With Advanced Gynecologic Cancers and Triple-Negative Breast Cancer

Who this might be right for
Gynecologic Neoplasms
Hoffmann-La Roche 29
Testing effectiveness (Phase 2)Study completedNCT00561795
What this trial is testing

Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors

Who this might be right for
Primary Peritoneal CarcinomaTumorEpithelial Ovarian Cancer+4 more
GlaxoSmithKline 12
Not applicableActive Not RecruitingNCT03794635
What this trial is testing

An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer

Who this might be right for
Metastatic CancerLocally Advanced CancerThoracic Cancer+3 more
Memorial Sloan Kettering Cancer Center 45
Not applicableLooking for participantsNCT05629611
What this trial is testing

Efficacy and Safety Evaluation of Vi-sealer

Who this might be right for
Benign Gynecologic Neoplasm
Hyun Park 280
Early research (Phase 1)Looking for participantsNCT07038369
What this trial is testing

ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Who this might be right for
Advanced Solid TumorsBreast CancerBreast Carcinoma+24 more
Atavistik Bio, Inc 134
Early research (Phase 1)Ended earlyNCT04682431
What this trial is testing

A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorGynecologic CancerBreast Cancer+5 more
Ikena Oncology 127
Not applicableStudy completedNCT06182332
What this trial is testing

An Artificial Intelligence Algorithm for Identifying Gynecologic Cancer Patients in Need of Outpatient Palliative Care

Who this might be right for
Advanced Malignant Female Reproductive System Neoplasm
Mayo Clinic 221
Not applicableStudy completedNCT02822820
What this trial is testing

The Comparison of Conventional and Advanced Bipolar Energy Modalities During Laparoscopic Staging Surgery of Gynecologic Cancers

Who this might be right for
Perioperative Period
Ankara University 68
Early research (Phase 1)Looking for participantsNCT06375187
What this trial is testing

GC203 TIL in Advanced Malignant Solid Tumors

Who this might be right for
Solid TumorGynecologic CancerBreast Cancer+2 more
Shanghai Juncell Therapeutics 18
Testing effectiveness (Phase 2)Looking for participantsNCT06522828
What this trial is testing

Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients

Who this might be right for
Advanced/recurrent Endometrial Cancer and Platinum-resistant Ovarian Cancer
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 80
Not applicableStudy completedNCT03260647
What this trial is testing

Risk Stratified Multidisciplinary Ambulatory Management of Malignant Bowel Obstruction in Gynecological Cancers

Who this might be right for
Gynecologic Cancer
University Health Network, Toronto 96
Load More Results